KLOW differs from GLOW in component count (4 vs 3), dominant component (BPC-157 vs GHK-Cu), total mass (80mg vs 70mg), and primary research application (joint/soft-tissue recovery vs dermal/cosmetic)
Causal associations between modifiable risk factors and intervertebral disc degeneration
demonstrated that GHK-Cu at nanomolar concentrations significantly increased collagen synthesis in fibroblast cultures roughly double the rate of non-collagen protein synthesis, indicating a selective effect on structural protein production (Maquart et al., 1988)
Separate research has shown that GHK-Cu peptide helps slow down the growth of cancerous tissue and prevent its formation [4, 11]
Get a Clinician-Supervised Post-Viral Recovery Protocol Through Meto Meto connects you with metabolic and hormonal health clinicians who understand both the complexity of long COVID and the evidence base for peptide therapy
Results vary depending on the severity of the injury and overall health status